Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma

References

Page 1

	Year	Citations
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria Jedd D. Wolchok, Axel Hoos, Steven O’Day, Clinical Cancer Research	2009	3.2K
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes Ulrich S. Schubert, Luis C. Antón, James S. Gibbs, Nature Protein ChemistryBiochemistryProtein FoldingMedicineNatural Sciences	2000	1.5K
Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditions Helmut Jonuleit, Ulrich Kühn, Gabriele Müller, European Journal of Immunology	1997	1.2K
Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy Casper Paludan, Dorothee Schmid, Markus Landthaler, Science Lysosomal AcidificationImmunologyViral PathogenesisPathologyAntigen Processing	2004	827
Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function Roman Spörri, Caetano Reis e Sousa Nature Immunology InflammationHelper FunctionAutoimmune DiseaseAdaptive Immune SystemImmunology	2005	605
Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40 Jacques Banchereau, Paolo De Paoli, Alain Vallé, Science	1991	546
Quantitating Protein Synthesis, Degradation, and Endogenous Antigen Processing Michael F. Princiotta, Diana Finzi, Shu‐Bing Qian, Immunity BiochemistryBiotechnologyImmunochemistryEndogenous Antigen ProcessingProtein Degradation	2003	520
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors Axel Heiser, Doris Coleman, Jens Dannull, Journal of Clinical Investigation	2002	489
Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells Viggo Van Tendeloo, Peter Ponsaerts, Filip Lardon, Blood	2001	456
Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? Jonathan W. Yewdell, Luis C. Antón, Jack R. Bennink The Journal of Immunology	1996	449

Page 1